SEC Form 4 · accession 0001424422-16-000035
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stephen Morlock
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 29, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 28, 2016 | A | 428,571 | $0.35 | A | 543,956 | D | |
| Common stockF1 | Nov 28, 2016 | A | 0 | $0.00 | A | 251,071 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to purchase common stockF4,F3,F2 | $0.35 | Nov 28, 2016 | A | 321,428 | A | — | — | Common stock | 321,428 | 496,428 | D |
Explanation of responses
- F1Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03
- F2Warrant expires 7 years from the exercisability date.
- F3Warrants become exercisable upon the later of the one year anniversary from issuance and receiving stockholder approval to increase the number of authorized shares of common stock.
- F4Includes 175,000 options to purchase common stock held by Mr. Morlock's trust.